文献速递乳腺USMR

有乳腺癌个人史患者的半年一次乳腺超声或MRI筛查

Semiannual Breast US or MRI Screening in Patients with a Personal History of Breast Cancer.
PubMed 文献 · Radiology · 2023-05-09

本研究回顾性分析2758例有乳腺癌个人史的无症状女性,在接受年度钼靶联合半年一次超声或MRI筛查后,共检出18例第二原发乳腺癌,其中44%为0期、39%为I期。MRI癌症检出率最高达每1000次检查17.1例,超声与MRI总体检出率分别为1.8和4.4每1000次检查(P=0.11)。

要点

  • 有乳腺癌个人史患者半年一次超声或MRI补充筛查可在前次超声阴性后检出第二原发乳腺癌。
  • 检出18例第二原发癌中44%为0期、39%为I期,MRI与超声均有检出。
  • 超声与MRI总体癌症检出率分别为1.8和4.4每1000次检查,差异未达统计学显著(P=0.11)。

核心结论

  • 对有乳腺癌个人史的无症状女性,半年一次补充超声或MRI筛查可在前次半年一次超声筛查阴性后检出第二原发乳腺癌。

研究设计与样本

  • 回顾性研究,纳入2015年1月至2018年6月诊断乳腺癌、并于2019年7月至2019年12月及随后2年内接受年度钼靶联合半年一次超声或MRI筛查的患者,最终队列2758例无症状女性(中位年龄53岁,范围20-84岁)。

诊断标准与关键数值

  • 共5615次超声和1807次MRI检查;在前次半年一次超声筛查阴性后检出18例乳腺癌,其中44%(8/18)为0期(MRI检出3例、超声检出5例),39%(7/18)为I期(MRI检出3例、超声检出4例);MRI癌症检出率最高达每1000次检查17.1例(8/467;95%CI:8.7,33.4);超声与MRI总体癌症检出率分别为每1000次检查1.8例(10/5615;95%CI:1.0,3.3)和4.4例(8/1807;95%CI:2.2,8.8),P=0.11。

临床应用与阅片要点

  • 对有乳腺癌个人史的患者,半年一次补充超声或MRI筛查可在前次超声阴性后检出第二原发乳腺癌,检出癌中0期和I期占比较高。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background The wide variability of screening imaging use in patients with a personal history of breast cancer (PHBC) warrants investigation of its comparative clinical effectiveness. While more intensive screening with US or MRI at an interval of less than 1 year could increase early-stage breast cancer detection, its benefit has not been established. Purpose To investigate the outcomes of semiannual multimodality screening in patients with PHBC. Materials and Methods An academic medical center database was retrospectively searched for patients diagnosed with breast cancer between January 2015 and June 2018 who had undergone annual mammography with either semiannual incidence US or MRI screening from July 2019 to December 2019 and three subsequent semiannual screenings over a 2-year period. The primary outcome was second breast cancers diagnosed during follow-up. Examination-level cancer detection and interval cancer rates were calculated. Screening performances were compared with χ2 or Fisher exact tests or a logistic model with generalized estimating equations. Results Our final cohort included 2758 asymptomatic women (median age, 53 years; range, 20-84 years). Among 5615 US and 1807 MRI examinations, 18 breast cancers were detected after negative findings on a prior semiannual incidence US screening examination; 44% (eight of 18) were stage 0 (three detected with MRI; five, with US), and 39% (seven of 18) were stage I (three detected with MRI; four, with US). MRI had a cancer detection rate up to 17.1 per 1000 examinations (eight of 467; 95% CI: 8.7, 33.4), and the overall cancer detection rates of US and MRI were 1.8 (10 of 5615; 95% CI: 1.0, 3.3) and 4.4 (eight of 1807; 95% CI: 2.2, 8.8) per 1000 examinations, respectively (P = .11). Conclusion Supplemental semiannual US or MRI screening depicted second breast cancers after negative findings at prior semiannual incidence US examination in patients with PHBC. © RSNA, 2023 Supplemental material is available for this article. See also the editorial by Berg in this issue.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Ha, Lee, Kim, et al. Semiannual Breast US or MRI Screening in Patients with a Personal History of Breast Cancer. Radiology. 2023. PMID: 37158719. doi:10.1148/radiol.221660

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。